<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article article-type="research-article" dtd-version="3.0" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0150532</article-id>
<article-id pub-id-type="publisher-id">PONE-D-15-42269</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pulmonology</subject><subj-group><subject>Chronic obstructive pulmonary disease</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Bacterial pathogens</subject><subj-group><subject>Pseudomonas aeruginosa</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Bacterial pathogens</subject><subj-group><subject>Pseudomonas aeruginosa</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Bacteria</subject><subj-group><subject>Pseudomonas</subject><subj-group><subject>Pseudomonas aeruginosa</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Mathematical and statistical techniques</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Statistics (mathematics)</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Imaging techniques</subject><subj-group><subject>Neuroimaging</subject><subj-group><subject>Computed axial tomography</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Neuroscience</subject><subj-group><subject>Neuroimaging</subject><subj-group><subject>Computed axial tomography</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Diagnostic medicine</subject><subj-group><subject>Diagnostic radiology</subject><subj-group><subject>Tomography</subject><subj-group><subject>Computed axial tomography</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Imaging techniques</subject><subj-group><subject>Diagnostic radiology</subject><subj-group><subject>Tomography</subject><subj-group><subject>Computed axial tomography</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Radiology and imaging</subject><subj-group><subject>Diagnostic radiology</subject><subj-group><subject>Tomography</subject><subj-group><subject>Computed axial tomography</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Database and informatics methods</subject><subj-group><subject>Database searching</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body fluids</subject><subj-group><subject>Mucus</subject><subj-group><subject>Sputum</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body fluids</subject><subj-group><subject>Mucus</subject><subj-group><subject>Sputum</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body fluids</subject><subj-group><subject>Mucus</subject><subj-group><subject>Sputum</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body fluids</subject><subj-group><subject>Mucus</subject><subj-group><subject>Sputum</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Research assessment</subject><subj-group><subject>Systematic reviews</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune response</subject><subj-group><subject>Inflammation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune response</subject><subj-group><subject>Inflammation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Inflammation</subject></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Bronchiectasis as a Comorbidity of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis</article-title>
<alt-title alt-title-type="running-head">Bronchiectasis COPD and Meta-Analysis</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Du</surname>
<given-names>Qingxia</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Jin</surname>
<given-names>Jianmin</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Liu</surname>
<given-names>Xiaofang</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Sun</surname>
<given-names>Yongchang</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Department of Respiratory Medicine and Department of Emergency, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, 100191 China</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Sethi</surname>
<given-names>Sanjay</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>University at Buffalo, State University of New York, UNITED STATES</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con" id="contrib001">
<p>Conceived and designed the experiments: QD YS. Performed the experiments: QD YS. Analyzed the data: QD XL. Contributed reagents/materials/analysis tools: QD JJ. Wrote the paper: QD YS.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">suny@ccmu.edu.cn</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>3</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>11</volume>
<issue>3</issue>
<elocation-id>e0150532</elocation-id>
<history>
<date date-type="received">
<day>24</day>
<month>9</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>2</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-year>2016</copyright-year>
<copyright-holder>Du et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0150532"/>
<abstract>
<sec id="sec001">
<title>Background</title>
<p>Bronchiectasis revealed by chest computed tomography in COPD patients and its comorbid effect on prognosis have not been addressed by large-sized studies. Understanding the presence of bronchiectasis in COPD is important for future intervention and preventing disease progression.</p>
</sec>
<sec id="sec002">
<title>Methods</title>
<p>Observational studies were identified from electronic literature searches in Cochrane library, PubMed, ScienceDirect databases, American Thoracic Society and European Respiratory Society meeting abstracts. A systematic review and meta-analysis of studies was performed to summarize the factors associated with bronchiectasis in COPD patients. Primary outcomes included the risks for exacerbation frequency, isolation of a potentially pathogenic microorganism, severe airway obstruction and mortality. Odds ratios (ORs) were pooled by random effects models.</p>
</sec>
<sec id="sec003">
<title>Results</title>
<p>Fourteen observational studies were eligible for the study. Compared with COPD without bronchiectasis, comorbid bronchiectasis in COPD increased the risk of exacerbation (1.97, 95% CI, 1.29–3.00), isolation of a potentially pathogenic microorganism (4.11, 95%CI, 2.16–7.82), severe airway obstruction (1.31, 95% CI, 1.09–1.58) and mortality (1.96, 95% CI, 1.04–3.70).</p>
</sec>
<sec id="sec004">
<title>Conclusions</title>
<p>The presence of bronchiectasis in patients with COPD was associated with exacerbation frequency, isolation of a potentially pathogenic microorganism, severe airway obstruction and mortality.</p>
</sec>
</abstract>
<funding-group>
<funding-statement>This work was supported by the National Natural Science Foundation of China (81170039 and 81470239) and the Beijing Natural Science Foundation (7152037 and 7153163).</funding-statement>
</funding-group>
<counts>
<fig-count count="5"/>
<table-count count="1"/>
<page-count count="13"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec005" sec-type="intro">
<title>Introduction</title>
<p>Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity and mortality around the world [<xref ref-type="bibr" rid="pone.0150532.ref001">1</xref>]. It is a complex and heterogeneous disease; the pathological and structural abnormalities, and clinical features vary greatly among patients despite having a similar lung function [<xref ref-type="bibr" rid="pone.0150532.ref002">2</xref>–<xref ref-type="bibr" rid="pone.0150532.ref003">3</xref>]. Identifying patient groups with unique specific characteristics and clinical consequences is needed to guide therapy and management of COPD, especially for those at high risk for exacerbation and mortality, in whom a specific intervention could be tested [<xref ref-type="bibr" rid="pone.0150532.ref004">4</xref>].</p>
<p>Thoracic computed tomography is currently a noninvasive imaging tool that holds promise for phenotyping in COPD, as it reveals significant differences in morphological changes in the lungs even with similar degree of airflow limitation [<xref ref-type="bibr" rid="pone.0150532.ref005">5</xref>]. Underlying structural changes in COPD, such as bronchiectasis, may also modulate exacerbation severity and contribute to morbidity associated with exacerbations [<xref ref-type="bibr" rid="pone.0150532.ref006">6</xref>]. In 2014, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) firstly describes bronchiectasis as one of the comorbidities of COPD [<xref ref-type="bibr" rid="pone.0150532.ref007">7</xref>]. Bronchiectasis and COPD share common characteristics in clinical presentations and pathophysiology such as chronic cough, sputum production, susceptibility to recurrent exacerbations and incompletely reversible airflow obstruction [<xref ref-type="bibr" rid="pone.0150532.ref008">8</xref>].</p>
<p>Several studies [<xref ref-type="bibr" rid="pone.0150532.ref009">9</xref>–<xref ref-type="bibr" rid="pone.0150532.ref011">11</xref>] have revealed an association between bronchiectasis and COPD, reporting that the presence of bronchiectasis in patients with COPD is associated with increased bronchial inflammation, frequent colonization of airway by potentially pathogenic microorganisms (PPMs) and severe airflow obstruction. However, another observational study [<xref ref-type="bibr" rid="pone.0150532.ref012">12</xref>] suggests that the number of exacerbations and bacterial colonization are not related to bronchiectasis in COPD patients.</p>
<p>Given the potentially important impact of coexistent bronchiectasis on COPD outcomes, we summarized the current data from observational cohort studies to investigate the association between bronchiectasis and COPD.</p>
</sec>
<sec id="sec006" sec-type="materials|methods">
<title>Methods</title>
<sec id="sec007">
<title>Literature Search Strategy and Study Identification</title>
<p>We followed the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement [<xref ref-type="bibr" rid="pone.0150532.ref013">13</xref>] to perform this systematic review. Two investigators independently and in duplicate conducted a systematic review of the literature search of Cochrane library, PubMed, ScienceDirect databases, and abstracts from American Thoracic Society and European Respiratory Society, as well as traced citations through July 30, 2015 to obtain all relevant published literature. Disease-specific search terms “COPD” and “chronic obstructive lung disease” were combined with “bronchiectasis” in all our searches. All subject headings and abstracts were examined.</p>
<p>The inclusion criteria are as follows: (1) clearly defined bronchiectasis as a primary comorbidity or in a subgroup of patients with COPD in the study; (2) the presence of bronchiectasis was assessed by chest computed tomography; (3) presented odds ratio (OR), hazard ratio (HR) and corresponding confidence interval (CI) for the presence of bronchiectasis on outcomes, or gave enough data to calculate these parameters. Studies are excluded: (1) if the presence of bronchiectasis was assessed by chest X-ray only; (2) if the study only included occupational and single sex subjects.</p>
</sec>
<sec id="sec008">
<title>Primary Outcomes</title>
<p>The outcomes are risks of COPD exacerbations, isolation of a PPM, severe airflow obstruction and overall mortality. Objective evidence of COPD exacerbations includes reporting an increase in at least two out of three clinical symptoms, hospital admission for a COPD exacerbation, emergency room visits, and prescription of antibiotic or corticosteroid courses. Objective evidence of a PPM includes positive sputum cultures for <italic>Haemophilus influenzae</italic>, <italic>Streptococcus pneumoniae</italic>, <italic>Moraxella catarrhalis</italic>, <italic>Haemophilus parainfluenzae</italic>, <italic>Staphylococcus aureus</italic>, <italic>Pseudomonas aeruginosa</italic>, <italic>Klebsiella pneumoniae</italic>, and other gram-negative bacteria[<xref ref-type="bibr" rid="pone.0150532.ref014">14</xref>–<xref ref-type="bibr" rid="pone.0150532.ref015">15</xref>].</p>
</sec>
<sec id="sec009">
<title>Data Abstraction and Quality Assessment</title>
<p>Two investigators (YS and QD) independently extracted the data. The extraction information was as follows: the first authors’ names, study locations, publication dates, follow-up periods, baseline characteristics of study populations, diagnostic methods of bronchiectasis, outcome of interest and covariates. The quality of cohort studies was evaluated by Newcastle-Ottawa Scale (available at: <ext-link ext-link-type="uri" xlink:href="http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp" xlink:type="simple">http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp</ext-link>).</p>
</sec>
<sec id="sec010">
<title>Data Synthesis and Analysis</title>
<p>The Stata version 12.0 SE (Stata Corp.) was used to calculate pooled effect sizes and 95% CIs. Statistical heterogeneity across studies was quantified using the I<sup>2</sup> statistic, and I<sup>2</sup>≧50% was considered a substantial level of heterogeneity[<xref ref-type="bibr" rid="pone.0150532.ref015">15</xref>]. As the study populations are substantially different, random effects model was used and individual study characteristics was explored.</p>
<p>Publication biases were evaluated by visually examining the symmetry of funnel plots [<xref ref-type="bibr" rid="pone.0150532.ref016">16</xref>], and P &lt; 0.1 indicates significant asymmetry. We also performed the Duval and Tweedie nonparametric “trim and fill” procedure to further assess the possible effect of publication bias [<xref ref-type="bibr" rid="pone.0150532.ref017">17</xref>].</p>
</sec>
</sec>
<sec id="sec011" sec-type="results">
<title>Results</title>
<sec id="sec012">
<title>Description of Included Studies</title>
<p>The process of selection of studies is shown in <xref ref-type="fig" rid="pone.0150532.g001">Fig 1</xref>. The study characteristics and findings are summarized in <xref ref-type="table" rid="pone.0150532.t001">Table 1</xref>. A total of 14 studies met the inclusion criteria, including 5329 COPD patients, and1572 (29.5%) patients were comorbid with bronchiectasis. Association of the presence of bronchiectasis with COPD exacerbations (ECOPD) [<xref ref-type="bibr" rid="pone.0150532.ref009">9</xref>–<xref ref-type="bibr" rid="pone.0150532.ref012">12</xref>,<xref ref-type="bibr" rid="pone.0150532.ref018">18</xref>, <xref ref-type="bibr" rid="pone.0150532.ref019">19</xref>,<xref ref-type="bibr" rid="pone.0150532.ref020">20</xref>]was reported in seven studies, isolation of PPMs[<xref ref-type="bibr" rid="pone.0150532.ref009">9</xref>,<xref ref-type="bibr" rid="pone.0150532.ref010">10</xref>,<xref ref-type="bibr" rid="pone.0150532.ref012">12</xref>,<xref ref-type="bibr" rid="pone.0150532.ref021">21</xref>,<xref ref-type="bibr" rid="pone.0150532.ref022">22</xref>]and specifically of <italic>Pseudomonas aeruginosa</italic> (<italic>P</italic>. <italic>aeruginosa</italic>) [<xref ref-type="bibr" rid="pone.0150532.ref009">9</xref>,<xref ref-type="bibr" rid="pone.0150532.ref010">10</xref>,<xref ref-type="bibr" rid="pone.0150532.ref023">23</xref>,<xref ref-type="bibr" rid="pone.0150532.ref024">24</xref>]in five and four studies respectively, severe airflow obstruction[<xref ref-type="bibr" rid="pone.0150532.ref009">9</xref>,<xref ref-type="bibr" rid="pone.0150532.ref011">11</xref>, <xref ref-type="bibr" rid="pone.0150532.ref012">12</xref>, <xref ref-type="bibr" rid="pone.0150532.ref018">18</xref>,<xref ref-type="bibr" rid="pone.0150532.ref019">19</xref>,<xref ref-type="bibr" rid="pone.0150532.ref025">25</xref>,<xref ref-type="bibr" rid="pone.0150532.ref026">26</xref>] in seven studies, mortality in four studies[<xref ref-type="bibr" rid="pone.0150532.ref010">10</xref>, <xref ref-type="bibr" rid="pone.0150532.ref019">19</xref>,<xref ref-type="bibr" rid="pone.0150532.ref023">23</xref>,<xref ref-type="bibr" rid="pone.0150532.ref027">27</xref>], and higher levels of inflammatory cytokines in three studies[<xref ref-type="bibr" rid="pone.0150532.ref010">10</xref>,<xref ref-type="bibr" rid="pone.0150532.ref011">11</xref>,<xref ref-type="bibr" rid="pone.0150532.ref021">21</xref>]which were not enough to conduct a meta-analysis.</p>
<fig id="pone.0150532.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0150532.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Flowchart of process of literature review and selection.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0150532.g001" xlink:type="simple"/>
</fig>
<table-wrap id="pone.0150532.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0150532.t001</object-id>
<label>Table 1</label> <caption><title>Characteristics of Included Studies in the Meta-analysis.</title></caption>
<alternatives>
<graphic id="pone.0150532.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0150532.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left">Author/year/country</th>
<th align="left">Duration</th>
<th align="left">Number (bronchiectasis/total COPD)</th>
<th align="left">Participants</th>
<th align="left">Diagnostic methods(bronchiectasis /PPM)</th>
<th align="center">Outcomes (Odd ratios)</th>
<th align="left">Adjustments/considerations</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">Katsura.H[<xref ref-type="bibr" rid="pone.0150532.ref027">27</xref>]/2001/ Japan</td>
<td align="left">five years</td>
<td align="left">unknown /157</td>
<td align="left">Age mean 79.2, severe COPD on long-term domiciliary oxygen therapy</td>
<td align="left">-</td>
<td align="left">Mortality 3.96(1.39–11.28).</td>
<td align="left">-</td>
</tr>
<tr>
<td align="left">Patel.I.S.[<xref ref-type="bibr" rid="pone.0150532.ref021">21</xref>]/2004/United Kingdom</td>
<td align="left">1,197 (804–1,941) days</td>
<td align="left">27/54</td>
<td align="left">Moderate and severe COPD in East London COPD Study.</td>
<td align="left">HRCT, by Smith/ Quantitative culture</td>
<td align="left">PPM(7.0,1.47–37.9); longer symptom recovery time at exacerbation (p &lt; 0.001).Higher levels of airway inflammatory cytokines.</td>
<td align="left">-</td>
</tr>
<tr>
<td align="left">Roche N [<xref ref-type="bibr" rid="pone.0150532.ref022">22</xref>]/2006/ France</td>
<td align="left">Two years</td>
<td align="left">23/118</td>
<td align="left">Age 68.4±12.1, consecutive hospitalized for ECOPD.</td>
<td align="left">HRCT / Quantitative culture</td>
<td align="left">Positive quantitative culture (2.61, 1.09–6.26).</td>
<td align="left">-</td>
</tr>
<tr>
<td align="left">Garcia-Vidal.C[<xref ref-type="bibr" rid="pone.0150532.ref025">25</xref>]/2009/Spain</td>
<td align="left">One year</td>
<td align="left">46/88</td>
<td align="left">Age 72.11±10.0, consecutive hospitalized for ECOPD.</td>
<td align="left">HRCT</td>
<td align="left">Severe airflow obstruction (1.27, 0.99–1.64).</td>
<td align="left">-</td>
</tr>
<tr>
<td align="left">Bafadhel M[<xref ref-type="bibr" rid="pone.0150532.ref026">26</xref>]/2011/ England</td>
<td align="left">mean 4.35 years</td>
<td align="left">20/75</td>
<td align="left">Age mean 69.1, recruited consecutively from respiratory clinics</td>
<td align="left">CT scans</td>
<td align="left">Severe airflow obstruction (0.97, 0.93–1.02).</td>
<td align="left">-</td>
</tr>
<tr>
<td align="left">Martinez-Garcia MA[<xref ref-type="bibr" rid="pone.0150532.ref012">12</xref>]/2011 /Spain</td>
<td align="left">2004–2006</td>
<td align="left">53/92</td>
<td align="left">Age 71.3+9.3, moderate and severe COPD</td>
<td align="left">HRCT/by Naidich/ quantitative culture</td>
<td align="left">Severe airflow obstruction (3.87, 1.38–10.5); PPM (3.59, 1.3–9.9); ECOPD (3.07, 1.07–8.77).</td>
<td align="left">Gender, age, smoking, treatment, MRC dyspnea, daily sputum.</td>
</tr>
<tr>
<td align="left">Stewart JI[<xref ref-type="bibr" rid="pone.0150532.ref018">18</xref>]/2012/ United States</td>
<td align="left">2009–2011</td>
<td align="left">758/3636</td>
<td align="left">65.5 ± 8.1 vs. 62.8 ± 8.6 years</td>
<td align="left">CT</td>
<td align="left">Severe airflow obstructive (1.13, 1.06–1.25); ECOPD (1.04,1.01–1.3).</td>
<td align="left">-</td>
</tr>
<tr>
<td align="left">Eman O. Arram[<xref ref-type="bibr" rid="pone.0150532.ref009">9</xref>]/ 2012/ Egypt</td>
<td align="left">median 23 months</td>
<td align="left">33/69</td>
<td align="left">Age 67±9, moderate and severe COPD.</td>
<td align="left">HRCT/ Sputum cultures</td>
<td align="left">Severe airflow obstructive (3.61, 1.33–9.83); PPM (2.42, 0.09–6.46); <italic>P</italic>.<italic>Aeruginosa</italic> (18.57, 5.54–62.30); ECOPD (4.75, 1.67–13.52).</td>
<td align="left">-</td>
</tr>
<tr>
<td align="left">Martine-Garcia MA[<xref ref-type="bibr" rid="pone.0150532.ref010">10</xref>] /2013/ Spain</td>
<td align="left">median 48 months</td>
<td align="left">115/201</td>
<td align="left">Age 70.3±8.9, moderate and severe COPD.</td>
<td align="left">HRCT / by Naidich</td>
<td align="left">Mortality (2.54, 1.16–5.56); ECOPD(2.34,1.36–4.01); PPM(7.69,2.87–20.56); higher CRP(P = 0.018) <italic>P</italic>.<italic>Aeruginosa</italic>(3.08, 0.98–9.6).</td>
<td align="left">Age, post-bronchodilator FEV1% value, MRC dyspnea,PO2, body mass index, presence of PPM in sputum, presence of daily sputum production, number of severe exacerbations, Charlson Index, and peripheral albumin and ultrasensitive CRP concentration.</td>
</tr>
<tr>
<td align="left">Tulek B[<xref ref-type="bibr" rid="pone.0150532.ref011">11</xref>]/2013/ Turkey</td>
<td align="left">two years</td>
<td align="left">27/80</td>
<td align="left">Age 68±8, out-patients COPD</td>
<td align="left">HRCT/ by modified Bhalla scoring system</td>
<td align="left">Severe airflow obstructive (1.77,1.26–2.53); higher CRP levels;ECOPD (2.08,1.20–3.60);</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Timothy Gatheral[<xref ref-type="bibr" rid="pone.0150532.ref023">23</xref>]/2014/ United Kingdom</td>
<td align="left">3.5(0.9–6.6) years.</td>
<td align="left">278/406</td>
<td align="left">Age 71±11, admitted with first exacerbation.</td>
<td align="left">CT scans</td>
<td align="left"><italic>P</italic>.<italic>Aeruginosa</italic>(1.39, 1.07–1.80), mortality HR (1.05, 0.95–1.17); Inpatient days (p &lt; 0.001)</td>
<td align="left">Age, gender, Charlson Index, and increasing severity emphysema and bronchial wall thickening.</td>
</tr>
<tr>
<td align="left">Gallego M[<xref ref-type="bibr" rid="pone.0150532.ref024">24</xref>]/2014/ Spain</td>
<td align="left">over one year 1003 ± 306 days</td>
<td align="left">56/118</td>
<td align="left">Age 69.5 ± 8.2, a post bronchodilator FEV1 below 50%.</td>
<td align="left">HRCT / by Smith.</td>
<td align="left"><italic>P</italic>. <italic>aeruginosa</italic> (OR 9.8, 95% CI: 1.7 to 54.8)</td>
<td align="left">Age, smoking history, FEV1, body mass index, BODE score, co-morbidities, influenza and pneumococcal vaccination and long-term oxygen therapy use.</td>
</tr>
<tr>
<td align="left">Sadigov AS[<xref ref-type="bibr" rid="pone.0150532.ref019">19</xref>]/ 2014/ Azerbaijan</td>
<td align="left">Cohort/ Median 12 months</td>
<td align="left">26/54</td>
<td align="left">Consecutive patients with severe and very severe COPD</td>
<td align="left">HRCT/-</td>
<td align="left">Severe airflow obstructive (1.77,1.0–3.12);Mortality (2.15,1.28–3.59); ECOPD(2.2,1.31–3.7).</td>
<td align="left">Unadjusted</td>
</tr>
<tr>
<td align="left">Jairam PM [<xref ref-type="bibr" rid="pone.0150532.ref020">20</xref>]/2015/ Netherlands</td>
<td align="left">case–cohort study / median 4.4 years</td>
<td align="left">110/338</td>
<td align="left">routine chest CT scanning for non-pulmonary indications</td>
<td align="left">Routine diagnostic chest CT/ pulmonary lobe-based visual grading system</td>
<td align="left">ECOPD(1.5,0.9–2.5)</td>
<td align="left">-</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>CI = confidence interval; CRP = C-reaction protein; ECOPD = exacerbation of COPD; HR = hazard ratio; HRCT = High-resolution computed tomography; OR = odds ratio; <italic>P</italic>. <italic>aeruginosa</italic> = <italic>Pseudomonas aeruginosa</italic>; PPM = potentially pathogenic microorganism.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec013">
<title>Quality of Included Studies</title>
<p>All these studies were observational cohorts, and thus there were limitations in the interpretation of causality and in methodologies. The sample size ranged from 54 to 3636, and seven studies had a small population (N&lt;100), while three studies were published in abstracts [<xref ref-type="bibr" rid="pone.0150532.ref018">18</xref>, <xref ref-type="bibr" rid="pone.0150532.ref019">19</xref>, <xref ref-type="bibr" rid="pone.0150532.ref027">27</xref>]. One study was conducted in the United States, 2 in the United Kingdom, 4 in Spain, 1 in France, 1 in Egypt, 1 in Azerbaijan, and 1 in Turkey. Follow-up varied from one year [<xref ref-type="bibr" rid="pone.0150532.ref024">24</xref>] to five years [<xref ref-type="bibr" rid="pone.0150532.ref027">27</xref>]. Most studies lacked adjustment for potential confounders. In seven articles, bronchiectasis was graded by scoring systems proposed by Smith [<xref ref-type="bibr" rid="pone.0150532.ref021">21</xref>, <xref ref-type="bibr" rid="pone.0150532.ref024">24</xref>], Naidich [<xref ref-type="bibr" rid="pone.0150532.ref010">10</xref>, <xref ref-type="bibr" rid="pone.0150532.ref012">12</xref>] and Bhalla [<xref ref-type="bibr" rid="pone.0150532.ref011">11</xref>], and other systems [<xref ref-type="bibr" rid="pone.0150532.ref018">18</xref>, <xref ref-type="bibr" rid="pone.0150532.ref020">20</xref>] respectively. Selection of subjects was either from primary care, outpatient recruitment, or from hospitalization. The main outcomes of the studies are described as follows. The quality of each study, assessed by the Newcastle-Ottawa Scale, was displayed in Table A in <xref ref-type="supplementary-material" rid="pone.0150532.s001">S1 File</xref> (median score, 8.5; range, 7 to 9.).</p>
</sec>
<sec id="sec014">
<title>Bronchiectasis Exposure and Risk for COPD exacerbations</title>
<p><xref ref-type="fig" rid="pone.0150532.g002">Fig 2</xref> presents ORs (with 95% CIs) for all seven studies assessing the association between bronchiectasis exposure and risk for COPD exacerbations. The pooled ORs of 1.97 (95% CI, 1.29–3.00) indicated that comorbid bronchiectasis was associated with COPD exacerbations. There was a high heterogeneity among studies (I<sup>2</sup> = 80.2%, P&lt;0.01).Two studies [<xref ref-type="bibr" rid="pone.0150532.ref021">21</xref>, <xref ref-type="bibr" rid="pone.0150532.ref023">23</xref>] reported longer time to recovery from exacerbation in COPD patients with bronchiectasis.</p>
<fig id="pone.0150532.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0150532.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Odd ratios for the association between comorbid bronchiectasis and risk for COPD exacerbations.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0150532.g002" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec015">
<title>Bronchiectasis Exposure and Risk for Isolation of Potentially Pathogenic Microorganisms</title>
<p><xref ref-type="fig" rid="pone.0150532.g003">Fig 3</xref> presents ORs (with 95% CIs) for all five studies assessing the risk for isolation of a PPM and four studies specifically on <italic>P</italic>. <italic>aeruginosa</italic>. The pooled ORs for a PPM of 3.76 (95% CI, 2.37–5.96) and for <italic>P</italic>. <italic>aeruginosa</italic> of 4.75 (95% CI, 1.25–18.04) indicated that the presence of bronchiectasis was associated with increased risk for isolation of PPMs in the airways. There was no evidence of statistical heterogeneity of ORs for all PPMs across studies (P = 0.401; I<sup>2</sup> = 0.9%), but significant heterogeneity among studies reporting isolation of <italic>P</italic>. <italic>aeruginosa</italic> (I<sup>2</sup> = 86.5%, P&lt;0.01).</p>
<fig id="pone.0150532.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0150532.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Odd ratios for the association between comorbid bronchiectasis and risk for isolation of a potentially pathogenic microorganism.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0150532.g003" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec016">
<title>Bronchiectasis Exposure and Risk for Severe Airway Obstruction</title>
<p><xref ref-type="fig" rid="pone.0150532.g004">Fig 4</xref> presents ORs (with 95% CIs) for all seven studies assessing the association between the presence of bronchiectasis and risk for severe airway obstruction. The pooled ORs of 1.31 (95% CI, 1.09–1.58) indicated that the presence of bronchiectasis was associated with increased risk for severe airway obstruction. Significant between-studies heterogeneity was evident and the I<sup>2</sup> (P&lt;0.01) was 84.7%, indicating that 84.7% of the observed variance came from real differences between the studies.</p>
<fig id="pone.0150532.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0150532.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Odd ratios for the association between comorbid bronchiectasis and risk for severe airway obstruction.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0150532.g004" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec017">
<title>Bronchiectasis Exposure and Risk for Mortality</title>
<p><xref ref-type="fig" rid="pone.0150532.g005">Fig 5</xref> presents ORs (with 95% CIs) for all four studies assessing the association between the presence of bronchiectasis and mortality. The pooled ORs of 1.96 (95% CI, 1.04–3.70) indicated that the presence of bronchiectasis was associated with increased risk for mortality. Only one study [<xref ref-type="bibr" rid="pone.0150532.ref023">23</xref>] reported no correlation between the presence of bronchiectasis and survival, but in this study the authors showed that patients with bronchiectasis had a shorter survival following CT scan (2.6 (0.5–6.7) years) than those with no evidence of bronchiectasis (3.8(1.4–6.6) years) (p = 0.046). Significant between-studies heterogeneity and substantial variance were evident (I<sup>2</sup> = 82.9%, P = 0.001).</p>
<fig id="pone.0150532.g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0150532.g005</object-id>
<label>Fig 5</label>
<caption>
<title>Odd ratios for the association between comorbid bronchiectasis and risk for mortality.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0150532.g005" xlink:type="simple"/>
</fig>
<p>There was high heterogeneity among all studies, which was mostly due to clinical heterogeneity of the various study settings and populations. In addition, funnel plots were produced and yielded significant evidence of publication bias. The Begg’s tests were also statistically significant (P&lt;0.00). We undertook sensitivity analysis using the trim and fill method, which conservatively imputed hypothetical negative unpublished studies to mirror the positive studies and produced a symmetrical funnel plot (Figs A, B, C,D in <xref ref-type="supplementary-material" rid="pone.0150532.s001">S1 File</xref>) [<xref ref-type="bibr" rid="pone.0150532.ref017">17</xref>], and the pooled analysis incorporating the hypothetical studies continued to show a statistically significant association between bronchiectasis and outcomes.</p>
</sec>
</sec>
<sec id="sec018" sec-type="conclusions">
<title>Discussion</title>
<p>In this meta-analysis, we found that bronchiectasis revealed by chest CT was common in COPD patients, and these patients were more likely to have exacerbations or a longer recovery time from exacerbations. They also had a higher risk for isolation of a PPM including <italic>P</italic>. <italic>aeruginosa</italic> from sputum, and for more severe airflow obstruction than subjects without bronchiectasis. Finally, COPD patients with bronchiectasis may have a higher mortality risk. Therefore, the presence of bronchiectasis is no mere radiological findings but has a real impact on the natural history of COPD itself and could be of prognostic value in the evaluation and management of the disease.</p>
<p>Exacerbations of COPD are important events in the course of the disease because they have a negative impact on a patient’s quality of life, accelerate lung function decline, and are associated with morbidity and mortality [<xref ref-type="bibr" rid="pone.0150532.ref007">7</xref>]. The most common cause of exacerbations of COPD is believed to be respiratory tract infection [<xref ref-type="bibr" rid="pone.0150532.ref007">7</xref>]. However, the cause about one-third of severe exacerbations of COPD cannot be identified [<xref ref-type="bibr" rid="pone.0150532.ref007">7</xref>]. One study showed that some patients were particularly prone to exacerbations, and were defined as frequent exacerbators[<xref ref-type="bibr" rid="pone.0150532.ref028">28</xref>]. The reasons why the presence of bronchiectasis in COPD can be related to more frequent and longer duration of exacerbations are speculative. Recurrent COPD exacerbations are associated with the presence of heightened airway bacterial and inflammatory burden [<xref ref-type="bibr" rid="pone.0150532.ref029">29</xref>, <xref ref-type="bibr" rid="pone.0150532.ref030">30</xref>] and worsening of GOLD spirometric grades [<xref ref-type="bibr" rid="pone.0150532.ref028">28</xref>, <xref ref-type="bibr" rid="pone.0150532.ref031">31</xref>]. In this meta-analysis, we found that the presence of bronchiectasis in COPD patients was also related to isolation of PPMs and poor lung function. Chronic bacterial infection, especially by <italic>P</italic>. <italic>aeruginosa</italic>, was associated with more advanced disease and mortality in both COPD and bronchiectasis patients [<xref ref-type="bibr" rid="pone.0150532.ref032">32</xref>–<xref ref-type="bibr" rid="pone.0150532.ref035">35</xref>]. The presence of bacteria in the lower airways in COPD impairs host defense mechanisms, which results in epithelial cell integrity disruption and inflammation, further airway structural damage, which could be the mechanism for longer and more severe COPD exacerbations [<xref ref-type="bibr" rid="pone.0150532.ref019">19</xref>]. Incomplete resolution of bacterial infection or bacterial colonization was considered to be a risk for relapse, and therefore appropriate and effective antibiotic therapy for bacterial infection in exacerbation of COPD with bronchiectasis may be important in preventing exacerbations and relapses or delaying subsequent exacerbations [<xref ref-type="bibr" rid="pone.0150532.ref036">36</xref>–<xref ref-type="bibr" rid="pone.0150532.ref038">38</xref>]. But to date, appropriate modalities for bacterial eradication, particularly for those with chronic bacterial colonization, haven’t been established.</p>
<p>The association between the presence of bronchiectasis and COPD mortality is a remarkable finding of our study. This could be explained by the potential impact of brochiectasis on COPD. Firstly, the presence of bronchiectasis is associated with an increased risk for exacerbations. It is well known that exacerbations accelerate the rate of decline of lung function and are associated with significant mortality. Secondly, bronchiectasis is associated with severe airflow obstruction, which is also a risk for COPD death [<xref ref-type="bibr" rid="pone.0150532.ref028">28</xref>, <xref ref-type="bibr" rid="pone.0150532.ref031">31</xref>]. Thirdly, bronchiectasis is associated with systemic and pulmonary inflammation, which may be the mechanistic link between COPD and comorbid conditions, such as cardiovascular diseases, lung cancer and others which are also contributors to mortality [<xref ref-type="bibr" rid="pone.0150532.ref039">39</xref>].</p>
<p>The cause and effect relationship between bronchiectasis and COPD is still controversial. It is possible that chronic infection by bacteria in the airways of COPD may form a vicious cycle of structural damage, loss of epithelial cell integrity, impaired mucociliary clearance, and mucus hyper-secretion which results in further mucosal injury and inflammation [<xref ref-type="bibr" rid="pone.0150532.ref040">40</xref>–<xref ref-type="bibr" rid="pone.0150532.ref042">42</xref>]. Persistent airway inflammation with ensuing tissue injury and remodeling may induce bronchiectasis.</p>
<p>Our study has a number of strengths. Firstly, to the best of our knowledge, the present meta-analysis provides the most comprehensive data about the association between bronchiectasis in COPD and clinical outcomes. One of recent meta-analysis [<xref ref-type="bibr" rid="pone.0150532.ref043">43</xref>] on this topic was performed on limited studies (larger studies such as the COPDgene CT results were not included) and had not enough data to draw conclusion on mortality. Furthermore, they included a study of selected COPD patients with bronchial wall thickening rather than evident bronchiectasis [<xref ref-type="bibr" rid="pone.0150532.ref044">44</xref>]. Secondly, we followed the PRISMA statement guidelines [<xref ref-type="bibr" rid="pone.0150532.ref013">13</xref>] to identify, screen and describe the protocols in this systematic review, including a very sensitive systematic literature search strategy, an independent and duplicate selection and data abstraction processes, and a strict evaluation of study quality. Finally, to minimize the possibility of publication bias, we included three high-quality abstracts data from American Thoracic Society and European Respiratory Society.</p>
<p>It also needs to be mentioned that this meta-analysis has several limitations. Firstly, it was not possible to grade COPD by lung function in all the studies, and therefore, the precise prevalence of bronchiectasis in different stages of COPD cannot be calculated. Secondly, the selected publications are of varying definitions and quality with regards to defining the severity of COPD and the specific CT findings (particularly extent and severity of bronchiectasis) for each patient. Only five of the studies used a scoring tool to measure the degree of bronchiectasis, but none of these studies described a testing phase to show that the scoring tool was fit-for-purpose in their populations. This makes pooling of the data somewhat problematic and perhaps explains some of the heterogeneity noted among studies. Thirdly, although the primary objective of this study was to assess the effects of bronchiectasis on COPD clinical outcomes, the available data from these studies provide evidence for an association but do not establish causality. Lastly, there are limitations in the methodological quality of the included studies. No prospective large cohort study was found; the included studies were relatively small in size, and most of the patients were with moderate to severe airway obstruction.</p>
<p>Despite these, the available data are still sufficient for us to perform a reliable meta-analysis. Our results support that coexistent bronchiectasis in patients with COPD is associated with worse respiratory symptoms, higher risk for exacerbations and mortality. For improving symptoms and reducing future risks, this subgroup of patients may need more directed therapies targeting chronic mucus production and airway bacterial infection in addition to recommended treatments for COPD.</p>
</sec>
<sec id="sec019" sec-type="conclusions">
<title>Conclusions</title>
<sec id="sec020">
<title>Implications for clinical practice</title>
<p>This study adds to the fast growing evidence of the association between bronchiectasis and poor outcomes in COPD. It has important implications for our current practice and approach to the evaluation and management of COPD, because COPD patients with comorbid bronchiectasis may benefit from specific therapies.</p>
</sec>
<sec id="sec021">
<title>Implications for Research</title>
<p>Well designed prospective studies are clearly needed to explore the clinical significance of detection of bronchiectasis by HRCT in the management of COPD. Further higher-quality and longer-term studies are also needed to address the causal relationship between bronchiectasis and COPD clinical outcomes, as well as the therapeutic benefit of targeting bronchietasis (such as antibiotics) in COPD. Clearly, the pathophysiological mechanisms underlying the coexistence of bronchiectasis and COPD, and the candidate genes associated with the bronchiectasis phenotype of COPD are awaiting further studies.</p>
</sec>
</sec>
<sec id="sec022">
<title>Supporting Information</title>
<supplementary-material id="pone.0150532.s001" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pone.0150532.s001" xlink:type="simple">
<label>S1 File</label>
<caption>
<title/>
<p>Table A, The Quality of Observational Studies Assessed by Newcastle–Ottawa Scale. Table B, List of the 48 full-text excluded articles. Fig A, Funnel plots of publication bias for comorbid bronchiectasis and risk for COPD exacerbations. Fig B, Funnel plots of publication bias for comorbid bronchiectasis and risk for isolation of PPMs and P. Aeruginosa. Fig C, Funnel plots of publication bias for comorbid bronchiectasis and risk for airway severe obstruction. Fig D, Funnel plots of publication bias for comorbid bronchiectasis and risk for mortality. Appendix 1, Commands for each figure.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0150532.s002" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pone.0150532.s002" xlink:type="simple">
<label>S2 File</label>
<caption>
<title>PRISMA Checklist.</title>
<p>(DOC)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0150532.s003" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" xlink:href="info:doi/10.1371/journal.pone.0150532.s003" xlink:type="simple">
<label>S3 File</label>
<caption>
<title>Primary data for each figure.</title>
<p>(XLSX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="pone.0150532.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chapman</surname> <given-names>K R</given-names></name>, <name name-style="western"><surname>Mannino</surname> <given-names>D M</given-names></name>, <name name-style="western"><surname>Soriano</surname> <given-names>J B</given-names></name>, <name name-style="western"><surname>Vermeire</surname> <given-names>P A</given-names></name>, <name name-style="western"><surname>Buist</surname> <given-names>A S</given-names></name>, <name name-style="western"><surname>Thun</surname> <given-names>M J</given-names></name>, <etal>et al</etal>. <article-title>Epidemiology and costs of chronic obstructive pulmonary disease</article-title>. <source>Eur Respir J</source>. <year>2006</year>; <volume>27</volume>(<issue>1</issue>):<fpage>188</fpage>–<lpage>207</lpage>. <object-id pub-id-type="pmid">16387952</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pillai</surname> <given-names>S G</given-names></name>, <name name-style="western"><surname>Ge</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Zhu</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Kong</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Shianna</surname> <given-names>K V</given-names></name>, <name name-style="western"><surname>Need</surname> <given-names>A C</given-names></name>, <etal>et al</etal>. <article-title>A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci</article-title>. <source>Plos Genet</source>.<year>2009</year>;<volume>5</volume>(<issue>3</issue>):<fpage>e1000421</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pgen.1000421" xlink:type="simple">10.1371/journal.pgen.1000421</ext-link></comment> <object-id pub-id-type="pmid">19300482</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mannino</surname> <given-names>D M</given-names></name>. <article-title>COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity</article-title>. <source>Chest</source>. <year>2002</year>;<volume>121</volume>(<issue>suppl5</issue>): <fpage>121S</fpage>–<lpage>126S</lpage>.</mixed-citation></ref>
<ref id="pone.0150532.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Han</surname> <given-names>M L K</given-names></name>, <name name-style="western"><surname>Agusti</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Calverley</surname> <given-names>P M</given-names></name>, <name name-style="western"><surname>Celli</surname> <given-names>B R</given-names></name>, <name name-style="western"><surname>Criner</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Curtis</surname> <given-names>J L</given-names></name>, <etal>et al</etal>. <article-title>Chronic obstructive pulmonary disease phenotypes: the future of COPD</article-title>. <source>Am J Respir Crit Care Med</source>. <year>2010</year>;<volume>182</volume>(<issue>5</issue>):<fpage>598</fpage>–<lpage>604</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1164/rccm.200912-1843CC" xlink:type="simple">10.1164/rccm.200912-1843CC</ext-link></comment> <object-id pub-id-type="pmid">20522794</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Han</surname> <given-names>M L K</given-names></name>. <article-title>Clinical Correlations of Computed Tomography Imaging in Chronic Obstructive Pulmonary Disease</article-title>. <source>Ann Am Thorac Soc</source>. <year>2013</year>;<volume>10</volume>(<issue>Suppl</issue>):<fpage>S131</fpage>–<lpage>S137</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1513/AnnalsATS.201303-046AW" xlink:type="simple">10.1513/AnnalsATS.201303-046AW</ext-link></comment> <object-id pub-id-type="pmid">24313763</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wedzicha</surname> <given-names>J A</given-names></name>, <name name-style="western"><surname>Hurst</surname> <given-names>J R</given-names></name>. <article-title>Structural and functional co-conspirators in chronic obstructive pulmonary disease exacerbations</article-title>. <source>Proc Am Thorac Soc</source>. <year>2007</year>;<volume>4</volume>(<issue>8</issue>):<fpage>602</fpage>–<lpage>605</lpage>. <object-id pub-id-type="pmid">18073390</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref007"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2014)[EB/ OL]. Available: <ext-link ext-link-type="uri" xlink:href="http://www.goldcopd.org/" xlink:type="simple">http://www.goldcopd.org/</ext-link> Global Initiative for Chronic Obstructive Lung Disease.</mixed-citation></ref>
<ref id="pone.0150532.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Novosad</surname> <given-names>S A</given-names></name>, <name name-style="western"><surname>Barker</surname> <given-names>A F</given-names></name>. <article-title>Chronic obstructive pulmonary disease and bronchiectasis</article-title>. <source>Curr Opin Pulm Med</source>. <year>2013</year>;<volume>19</volume>(<issue>2</issue>):<fpage>133</fpage>–<lpage>139</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/MCP.0b013e32835d8312" xlink:type="simple">10.1097/MCP.0b013e32835d8312</ext-link></comment> <object-id pub-id-type="pmid">23287285</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Arram</surname> <given-names>E O</given-names></name>, <name name-style="western"><surname>Elrakhawy</surname> <given-names>M M</given-names></name>. <article-title>Bronchiectasis in COPD patients</article-title>. <source>Egyptian Journal of Chest Diseases and Tuberculosis</source>. <year>2012</year>;<volume>61</volume>(<issue>4</issue>):<fpage>307</fpage>–<lpage>312</lpage>.</mixed-citation></ref>
<ref id="pone.0150532.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Martínez-García</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>de la Rosa</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Soler-Cataluña</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Donat-Sanz</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Serra</surname> <given-names>P C</given-names></name>, <name name-style="western"><surname>Lerma</surname> <given-names>M A</given-names></name>, <etal>et al</etal>. <article-title>Prognostic value of bronchiectasis in patients with moderate to severe chronic obstructive pulmonary disease</article-title>. <source>Am J Respir Crit Care Med</source>. <year>2013</year>;<volume>187</volume>:<fpage>823</fpage>–<lpage>831</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1164/rccm.201208-1518OC" xlink:type="simple">10.1164/rccm.201208-1518OC</ext-link></comment> <object-id pub-id-type="pmid">23392438</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tulek</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Kivrak</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Ozbek</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Kanat</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Suerdem</surname> <given-names>M</given-names></name>. <article-title>Phenotyping of chronic obstructive pulmonary disease using the modified Bhalla scoring system for high-resolution computed tomography</article-title>. <source>Can Respir J</source>. <year>2013</year>;<volume>20</volume>(<issue>2</issue>):<fpage>91</fpage>–<lpage>96</lpage>. <object-id pub-id-type="pmid">23616965</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Martinez-Garcia</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Soler-Cataluna</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Donat</surname> <given-names>Sanz Y</given-names></name>, <name name-style="western"><surname>Serra</surname> <given-names>P C</given-names></name>, <name name-style="western"><surname>Lerma</surname> <given-names>M A</given-names></name>, <name name-style="western"><surname>Vicente</surname> <given-names>J B</given-names></name>, <etal>et al</etal>. <article-title>Factors associated with bronchiectasis in patients with COPD</article-title>. <source>Chest</source>. <year>2011</year>;<volume>140</volume>:<fpage>1130</fpage>–<lpage>1137</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1378/chest.10-1758" xlink:type="simple">10.1378/chest.10-1758</ext-link></comment> <object-id pub-id-type="pmid">21546440</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moher</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Liberati</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Tetzlaff</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Altman</surname> <given-names>D G</given-names></name>. <article-title>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement</article-title>. <source>Ann Intern Med</source>. <year>2009</year>;<volume>151</volume>(<issue>4</issue>):<fpage>264</fpage>–<lpage>9</lpage>. <object-id pub-id-type="pmid">19622511</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rosell</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Monso</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Soler</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Torres</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Angrill</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Riise</surname> <given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease</article-title>. <source>Arch Intern Med</source>. <year>2005</year>;<volume>165</volume>:<fpage>891</fpage>–<lpage>897</lpage>. <object-id pub-id-type="pmid">15851640</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sethi</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Evans</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Grant</surname> <given-names>BJ</given-names></name>, <name name-style="western"><surname>Murphy</surname> <given-names>TF</given-names></name>. <article-title>New strains of bacteria and exacerbation of chronic obstructive pulmonary disease</article-title>. <source>N Engl J Med</source>. <year>2002</year>;<volume>347</volume>:<fpage>465</fpage>–<lpage>471</lpage>. <object-id pub-id-type="pmid">12181400</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higgins</surname> <given-names>J P T</given-names></name>, <name name-style="western"><surname>Thompson</surname> <given-names>S G</given-names></name>, <name name-style="western"><surname>Deeks</surname> <given-names>J J</given-names></name>, <name name-style="western"><surname>Altman</surname> <given-names>D G</given-names></name>. <article-title>Measuring inconsistency in meta-analyses</article-title>. <source>Bmj</source>. <year>2003</year>;<volume>327</volume>(<issue>7414</issue>):<fpage>557</fpage>–<lpage>560</lpage>. <object-id pub-id-type="pmid">12958120</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Duval</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Tweedie</surname> <given-names>R</given-names></name>. <article-title>Trim and fill: a simple funnel plot-based method of testing and adjusting for publication bias in meta-analysis</article-title>. <source>Biometrics</source>. <year>2000</year>;<volume>56</volume>(<issue>2</issue>):<fpage>455</fpage>–<lpage>463</lpage>. <object-id pub-id-type="pmid">10877304</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stewart</surname> <given-names>JI</given-names></name>, <name name-style="western"><surname>Maselli</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Anzueto</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Criner</surname> <given-names>G J</given-names></name>, <name name-style="western"><surname>Han</surname> <given-names>M K</given-names></name>, <name name-style="western"><surname>Martínez</surname> <given-names>F J</given-names></name>. <article-title>Clinical impact of CT radiological feature of bronchiectasis in the COPD Gene cohort</article-title>. <source>Am J Respir Crit Care Med</source>. <year>2012</year>;<volume>185</volume>:<fpage>A3656</fpage>.</mixed-citation></ref>
<ref id="pone.0150532.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sadigov</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Akhundov</surname> <given-names>S</given-names></name>. <article-title>Bronchiectasis associated with COPD: does it increase the mortality rate in patients with severe disease?</article-title> <source>Am J Respir Crit Care Med</source>. <volume>189</volume>;<year>2014</year>:<fpage>A4257</fpage>.</mixed-citation></ref>
<ref id="pone.0150532.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jairam</surname> <given-names>PM</given-names></name>, <name name-style="western"><surname>van der Graaf</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Lammers</surname> <given-names>J-WJ</given-names></name>, <name name-style="western"><surname>Willem</surname> <given-names>P T M</given-names></name>, <name name-style="western"><surname>de Jong</surname> <given-names>P A</given-names></name>, <name name-style="western"><surname>Laméris</surname> <given-names>J</given-names></name>. <article-title>Incidental findings on chest CT imaging are associated with increased COPD exacerbations and mortality</article-title>. <source>Thorax</source>. <year>2015</year>, <volume>70</volume>(<issue>8</issue>): <fpage>725</fpage>–<lpage>731</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/thoraxjnl-2014-206160" xlink:type="simple">10.1136/thoraxjnl-2014-206160</ext-link></comment> <object-id pub-id-type="pmid">26024687</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Patel</surname> <given-names>IS</given-names></name>, <name name-style="western"><surname>Vlahos</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Wilkinson</surname> <given-names>TMA</given-names></name>, <name name-style="western"><surname>Lloyd-Owen</surname> <given-names>S J</given-names></name>, <name name-style="western"><surname>Donaldson</surname> <given-names>G C</given-names></name>, <name name-style="western"><surname>Wilks</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease</article-title>. <source>Am. J. Respir. Crit. Care Med.</source> <year>2004</year>;<volume>170</volume>(<issue>4</issue>):<fpage>400</fpage>–<lpage>407</lpage>. <object-id pub-id-type="pmid">15130905</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Roche</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Kouassi</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Rabbat</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Mounedji</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Lorut</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Huchon</surname> <given-names>G</given-names></name>. <article-title>Yield of sputum microbiological examination in patients hospitalized for exacerbations of chronic obstructive pulmonary disease with purulent sputum</article-title>. <source>Respiration</source>. <year>2006</year>;<volume>74</volume>(<issue>1</issue>):<fpage>19</fpage>–<lpage>25</lpage>. <object-id pub-id-type="pmid">16675894</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gatheral</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Kumar</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Sansom</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Lai</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Nair</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Vlahos</surname> <given-names>I</given-names></name>, <etal>et al</etal>. <article-title>COPD-related bronchiectasis: independent impact on disease course and outcomes</article-title>. <source>COPD</source>. <year>2014</year>;<volume>11</volume>(<issue>6</issue>):<fpage>605</fpage>–<lpage>614</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3109/15412555.2014.922174" xlink:type="simple">10.3109/15412555.2014.922174</ext-link></comment> <object-id pub-id-type="pmid">24983298</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gallego</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Pomares</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Espasa</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Castañer</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Solé</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Suárez</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Pseudomonas aeruginosa isolates in severe chronic obstructive pulmonary disease: characterization and risk factors</article-title>. <source>Bmc Pulmonary Medicine</source>. <year>2014</year>;<volume>14</volume>(<issue>4</issue>):<fpage>48</fpage>–<lpage>48</lpage>.</mixed-citation></ref>
<ref id="pone.0150532.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>García-Vidal</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Almagro</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Romaní</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Rodriguez-Carballeira</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Cuchi</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Canales</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study</article-title>. <source>Eur Respir J</source>. <year>2009</year>;<volume>34</volume>:<fpage>1072</fpage>–<lpage>1078</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1183/09031936.00003309" xlink:type="simple">10.1183/09031936.00003309</ext-link></comment> <object-id pub-id-type="pmid">19386694</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bafadhel</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Umar</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Gupta</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Raj</surname> <given-names>J V</given-names></name>, <name name-style="western"><surname>Vara</surname> <given-names>D D</given-names></name>, <name name-style="western"><surname>Entwisle</surname> <given-names>J J</given-names></name>, <etal>et al</etal>. <article-title>The role of CT scanning in multidimensional phenotyping of COPD</article-title>. <source>Chest</source>. <year>2011</year>;<volume>140</volume>:<fpage>634</fpage>–<lpage>642</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1378/chest.10-3007" xlink:type="simple">10.1378/chest.10-3007</ext-link></comment> <object-id pub-id-type="pmid">21454400</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Katsura</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Ogata</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kida</surname> <given-names>K</given-names></name>. <article-title>Factors determining outcome in elderly patients with severe COPD on long-term domiciliary oxygen therapy</article-title>. <source>Arch Monaldi Mal Torace</source>. <year>2001</year>;<volume>56</volume>(<issue>3</issue>):<fpage>195</fpage>–<lpage>201</lpage>.</mixed-citation></ref>
<ref id="pone.0150532.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hurst</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Vestbo</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Anzueto</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Locantore</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Müllerova</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Tal-Singer</surname> <given-names>R</given-names></name>. <article-title>Susceptibility to exacerbation in chronic obstructive pulmonary disease</article-title>. <source>N Engl J Med</source>. <year>2010</year>;<volume>363</volume>(<issue>12</issue>):<fpage>1128</fpage>–<lpage>38</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMoa0909883" xlink:type="simple">10.1056/NEJMoa0909883</ext-link></comment> <object-id pub-id-type="pmid">20843247</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bhowmik</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Seemungal</surname> <given-names>TAR</given-names></name>, <name name-style="western"><surname>Sapsford</surname> <given-names>RJ</given-names></name>, <name name-style="western"><surname>Wedzicha</surname> <given-names>J A</given-names></name>. <article-title>Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations</article-title>. <source>Thorax</source>. <year>2000</year>;<volume>55</volume>:<fpage>114</fpage>–<lpage>120</lpage>. <object-id pub-id-type="pmid">10639527</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Patel</surname> <given-names>IS</given-names></name>, <name name-style="western"><surname>Seemungal</surname> <given-names>TAR</given-names></name>, <name name-style="western"><surname>Wilks</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Lloyd-Owen</surname> <given-names>S J</given-names></name>, <name name-style="western"><surname>Donaldson</surname> <given-names>G C</given-names></name>, <name name-style="western"><surname>Wedzicha</surname> <given-names>J A</given-names></name>. <article-title>Relationship between bacterial colonisation and the frequency, character and severity of COPD exacerbations</article-title>. <source>Thorax</source>. <year>2002</year>;<volume>57</volume>:<fpage>759</fpage>–<lpage>764</lpage>. <object-id pub-id-type="pmid">12200518</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Decramer</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Celli</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Kesten</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Lystig</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Mehra</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Tashkin</surname> <given-names>D P</given-names></name>. <article-title>Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial</article-title>. <source>Lancet</source>.<year>2009</year>;<volume>374</volume>:<fpage>1171</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0140-6736(09)61298-8" xlink:type="simple">10.1016/S0140-6736(09)61298-8</ext-link></comment> <object-id pub-id-type="pmid">19716598</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Davies</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Wells</surname> <given-names>A U</given-names></name>, <name name-style="western"><surname>Doffman</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Watanabe</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Wilson</surname> <given-names>R</given-names></name>. <article-title>The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis</article-title>. <source>Eur Respir J</source>. <year>2006</year>;<volume>28</volume>(<issue>5</issue>):<fpage>974</fpage>–<lpage>979</lpage>. <object-id pub-id-type="pmid">16899482</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Valderrey</surname> <given-names>A D</given-names></name>, <name name-style="western"><surname>Pozuelo</surname> <given-names>M J</given-names></name>, <name name-style="western"><surname>Maciá</surname> <given-names>M D</given-names></name>, <name name-style="western"><surname>Oliver</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Rotger</surname> <given-names>R</given-names></name>. <article-title>Chronic colonization by Pseudomonas aeruginosa of patients with obstructive lung diseases: cystic fibrosis, bronchiectasis, and chronic obstructive pulmonary disease</article-title>. <source>Diagn Microbiol Infect Dis</source>. <year>2010</year>;<volume>68</volume>(<issue>1</issue>)<fpage>20</fpage>–<lpage>27</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.diagmicrobio.2010.04.008" xlink:type="simple">10.1016/j.diagmicrobio.2010.04.008</ext-link></comment> <object-id pub-id-type="pmid">20727465</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Martínez-Solano</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Macia</surname> <given-names>M D</given-names></name>, <name name-style="western"><surname>Fajardo</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Oliver</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Martinez</surname> <given-names>J L</given-names></name>. <article-title>Chronic <italic>Pseudomonas aeruginosa</italic> infection in chronic obstructive pulmonary disease</article-title>. <source>Clin Infect Dis</source>. <year>2008</year>;<volume>47</volume>(<issue>12</issue>):<fpage>1526</fpage>–<lpage>1533</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1086/593186" xlink:type="simple">10.1086/593186</ext-link></comment> <object-id pub-id-type="pmid">18990062</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Davies</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Wells</surname> <given-names>A U</given-names></name>, <name name-style="western"><surname>Doffman</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Watanabe</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Wilson</surname> <given-names>R</given-names></name>. <article-title>The effect of <italic>Pseudomonas aeruginosa</italic> on pulmonary function in patients with bronchiectasis</article-title>. <source>Eur Respir J</source>. <year>2006</year>;<volume>28</volume>(<issue>5</issue>):<fpage>974</fpage>–<lpage>979</lpage>. <object-id pub-id-type="pmid">16899482</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Murray</surname> <given-names>M P</given-names></name>, <name name-style="western"><surname>Turnbull</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>MacQuarrie</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Hill</surname> <given-names>A T</given-names></name>. <article-title>Assessing response to treatment of exacerbations of bronchiectasis in adults</article-title>. <source>Eur Respir J</source>. <year>2009</year>;<volume>33</volume>(<issue>2</issue>):<fpage>312</fpage>–<lpage>318</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1183/09031936.00122508" xlink:type="simple">10.1183/09031936.00122508</ext-link></comment> <object-id pub-id-type="pmid">18829674</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>White</surname> <given-names>A J</given-names></name>, <name name-style="western"><surname>Gompertz</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Bayley</surname> <given-names>D L</given-names></name>, <name name-style="western"><surname>Hill</surname> <given-names>S L</given-names></name>, <name name-style="western"><surname>O’Brien</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Unsal</surname> <given-names>I</given-names></name>, <etal>et al</etal>. <article-title>Resolution of bacterial inflammation is related to bacterial eradication following treatment of exacerbation of chronic bronchitis</article-title>. <source>Thorax</source>. <year>2003</year>;<volume>58</volume>:<fpage>680</fpage>–<lpage>685</lpage>. <object-id pub-id-type="pmid">12885984</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wilson</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Anzueto</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Miravitlles</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Arvis</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Alder</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Haverstock</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results</article-title>. <source>Eur Respir J</source>. <year>2012</year>;<volume>40</volume>(<issue>1</issue>):<fpage>17</fpage>–<lpage>27</lpage>. 5. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1183/09031936.00090311" xlink:type="simple">10.1183/09031936.00090311</ext-link></comment> <object-id pub-id-type="pmid">22135277</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Berger</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Sanborn</surname> <given-names>TA</given-names></name>, <name name-style="western"><surname>Sherman</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Brown</surname> <given-names>D L</given-names></name>. <article-title>Effect of chronic obstructive pulmonary disease on survival of patients with coronary heart disease having percutaneous coronary intervention</article-title>. <source>Am J Cardiol</source>. <year>2004</year>;<volume>94</volume>:<fpage>649</fpage>–<lpage>51</lpage>. <object-id pub-id-type="pmid">15342301</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Adler</surname> <given-names>K B</given-names></name>, <name name-style="western"><surname>Hendley</surname> <given-names>D D</given-names></name>, <name name-style="western"><surname>Davis</surname> <given-names>G S</given-names></name>. <article-title>Bacteria associated with obstructive pulmonary disease elaborate extracellular products that stimulate mucin secretion by explants of guinea pig airways</article-title>. <source>Am. J. Pathol</source>. <year>1986</year>;<volume>125</volume>(<issue>3</issue>):<fpage>501</fpage>. <object-id pub-id-type="pmid">3099581</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Aziz</surname> <given-names>Z A</given-names></name>, <name name-style="western"><surname>Wells</surname> <given-names>A U</given-names></name>, <name name-style="western"><surname>Desai</surname> <given-names>S R</given-names></name>, <name name-style="western"><surname>Ellis</surname> <given-names>S M</given-names></name>, <name name-style="western"><surname>Walker</surname> <given-names>A E</given-names></name>, <name name-style="western"><surname>MacDonald</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Functional impairment in emphysema: contribution of airway abnormalities and distribution of parenchyma disease</article-title>. <source>AJR Am J Roentgenol</source>. <year>2005</year>;<volume>185</volume>(<issue>6</issue>):<fpage>1509</fpage>–<lpage>1515</lpage>. <object-id pub-id-type="pmid">16304005</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Habesoglu</surname> <given-names>M A</given-names></name>, <name name-style="western"><surname>Tercan</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Ozkan</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Ellis</surname> <given-names>S M</given-names></name>, <name name-style="western"><surname>Walker</surname> <given-names>A E</given-names></name>, <name name-style="western"><surname>MacDonald</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Effect of radiological extent and severity of bronchiectasis on pulmonary function</article-title>. <source>Multidiscip Respir Med</source>. <year>2011</year>;<volume>6</volume>(<issue>5</issue>):<fpage>284</fpage>–<lpage>290</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/2049-6958-6-5-284" xlink:type="simple">10.1186/2049-6958-6-5-284</ext-link></comment> <object-id pub-id-type="pmid">22958727</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ni</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Shi</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Yu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Hao</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Song</surname> <given-names>H</given-names></name>. <article-title>Clinical characteristics of patients with chronic obstructive pulmonary disease with comorbid bronchiectasis: a systemic review and meta-analysis</article-title>. <source>Int J Chron Obstruct Pulmon Dis</source>. <year>2015</year>, <volume>10</volume>: <fpage>1465</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2147/COPD.S83910" xlink:type="simple">10.2147/COPD.S83910</ext-link></comment> <object-id pub-id-type="pmid">26251586</object-id></mixed-citation></ref>
<ref id="pone.0150532.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fujimoto</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kitaguchi</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Kubo</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Honda</surname> <given-names>T</given-names></name>. <article-title>Clinical analysis of chronic obstructive pulmonary disease phenotypes classified using high-resolution computed tomography</article-title>. <source>Respirology</source>. <year>2006</year> <month>Nov</month>;<volume>11</volume>(<issue>6</issue>):<fpage>731</fpage>–<lpage>40</lpage>. <object-id pub-id-type="pmid">17052301</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>